Abstract
The α-adrenergic receptors (α-ARs) modulate a number of intracellular processes and among these α1a-adrenergic receptors play an important role in the regulation of physiological processes related to cardiovascular system. In view of its therapeutic potential, comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) studies were performed on a set of diverse α-AR antagonists to understand the structural factors affecting their antagonistic activity where both CoMFA (q 2train = 0.709, r 2train = 0.962, and r 2predictive = 0.629) and CoMSIA (q 2train = 0.648, r 2train = 0.949, and r 2predictive = 0.656) models gave statistical significant results. The generated CoMFA and CoMSIA models suggest that steric, electrostatic and hydrophobic interactions play an important role in describing the variation in antagonistic activity. Therefore, the models may be useful in the identification and optimization of novel scaffolds with potent α1a-adrenergic receptor antagonistic activity.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The α-adrenergic receptors (α-ARs) play a pivotal role in the regulation of a variety of physiological processes, particularly within the cardiovascular system and are divided into two main subtypes namely α1- and α2-ARs (Kulig et al., 2009). The α1-adrenergic receptors are widely distributed throughout the body and mediate number of physiological functions. The α1-ARs are mainly present in blood vessels (postsynaptic), smooth muscle (postsynaptic), heart (postsynaptic), eyes (postsynaptic), liver (postsynaptic), CNS (postsynaptic), sympathetic neurons (presynaptic) (Jain et al., 2008). In addition to blood pressure reduction, α1-ARs antagonists also show beneficiary effect on plasma lipoproteins. Recent study revealed that activation of α1a-ARs may be responsible for ischemia-induced cardiac arrhythmia (MacDougall and Griffith, 2006). Therefore, α1A-ARs antagonists may be useful for the treatment of ischemia-induced cardiac arrhythmia.
There are relatively few publications reporting the application of QSAR analysis to α1-AR species (Debnath et al., 2003; Fumagalli et al., 2005; Pallavicini et al., 2006; Shakya et al., 2004; Nowaczyk et al., 2009). A general α1-ARs pharmacophore developed by Barbaro et al. (2001) was based on pyridazinone derivatives (Fang et al., 2003) while Li et al. (2005) developed an α1a pharmacophore based on a diverse class of compounds. Recently, selective pharmacophore for α1-ARs subtype was developed by MacDougall and Griffith (2006) while α1d-ARs subtype specific pharmacophore was developed by Romeo et al. (2003). A CoMFA study on hexahydro and octahydropyrido[1,2-c]pyrimidine derivatives as α1a-AR antagonists has been reported (Maciejewska et al., 2006) while a self-organizing molecular field analysis (SOMFA) method to provide insight for the development of α1-adrenoceptor antagonists has been carried out by Li and Xia (2007)).
Since the exact crystal structure of α1a-adrenoreceptor is unknown and a little attention has been given to the QSAR studies using diverse classes of adrenergic antagonists, it appeared of interest to develop a quantitative 3D-QSAR model using the diverse classes of α1a-adrenoreceptor antagonists to find out the essential structural requirements for their antagonistic activity.
Materials and methods
The 3D-QSAR studies have been performed on a set of chemically diverse molecules belonging to 1,4-benzodioxane, 1,3-dioxolane, substituted piperazine, spiroethyl-phenylpiperazine, imido derivatives, non-imidospiro derivatives, spiroalkyl 2,5-dichlorophenylpiperazine and prazosin-related compounds reported in the literature (Quaglia et al., 1999, 2002, 2005, 2008; Brasili et al., 2003; Rosini et al., 2003; Leonardi et al., 2004; Franchini et al., 2009; Sorbi et al., 2009). The α1-AR antagonistic activity/binding affinity data of these compounds are expressed as K i value in the nanomolar (nM) range. The selected compounds with diverse structural features cover a wide range of biological activity spanning over more than 4 log units (0.05–2,684 nM). A correction factor for 20% lesser value of the activity data has been applied for the compounds reported in the paper (Leonardi et al., 2004) since the reference compound BMY 7378 showed 20% higher activity value than reported in other papers considered in the QSAR study. The K i values were converted into negative logarithm of K i (pK i) for the use in the QSAR studies.
Rational division of training and test sets
The 108 compounds in the dataset were distributed into five clusters according to their biological activity data and the training set compounds were picked up from generated clusters. It has been suggested that the generated models should be tested on a sufficiently large test set to establish a reliable QSAR model (Prathipati and Saxena, 2003); therefore, the molecules were rationally divided into training set of 45 (Fig. 1; Tables 1–6) and test set of 63 compounds, respectively, in such a way that they cover almost entire range of biological activity.
Computational approach and molecular alignment
Molecular modeling studies viz. CoMFA and CoMSIA were done on a Silicon Graphics Octane R12000 workstation using SYBYL6.9 molecular modeling software (Tripos, St. Louis, MO). All compounds were built using the most active compound 31 as a template in the ISIS Draw 2.5 and thereafter imported in sybyl 6.9. The partial charges for all the compounds were calculated using Gasteiger–Huckel method and were optimized for their geometry using Tripos force field with a distance-dependent dielectric function and energy convergence criterion of 0.001 kcal/mol Å using 1,000 iterations and standard SYBYL settings. Alignment is a critical step in the CoMFA studies and among the three more commonly suggested alignments in the literature viz. maximum common structure (MCS)-based alignment, rigid body field fit alignment and multifit alignment; the MCS-based alignment was used in the present study as it had given the best results similar to our earlier studies (Roy et al., 2008). The core (shown in bold) of the most active compound 31 (Fig. 2) was used for alignment (Fig. 3).
CoMFA studies
The steric (Lennard–Jonnes potentials) and electrostatic fields (Coulombic potentials) for CoMFA were calculated for the aligned molecules kept in 3D cubic lattice with a grid spacing of 2.0 Å in x, y and z directions using Tripos module in SYBYL. For each alignment a sp 3 carbon atom having a charge of +1 and a radius of 1.52 Å was used as a probe to calculate various steric and electrostatic fields. The influence of different parameter settings on CoMFA, various steric and electrostatic cutoffs and grid spacing was also tried as suggested by Crammer et al. (1988).
CoMSIA studies
The CoMSIA technique is based on the molecular similarity indices with the same lattice box used for the CoMFA calculations (Klebe et al., 1994). It is considered superior to CoMFA technique in certain aspects such as the results remain unaffected to both, region shifts as well as small shifts within the alignments, it does not require steric cutoffs and more intuitively interpretable contour maps. So, in the present study, standard settings of CoMSIA (probe with charge +1, radius 1 Å and hydrophobicity +1, hydrogen-bond donating +1, hydrogen-bond accepting +1, attenuation factor of 0.3 and grid spacing 2 Å) were used to calculate five different fields viz steric, electrostatic, hydrophobic, acceptor and donor.
Partial least square analysis
PLS is used to correlate α1a-adrenoreceptor antagonistic activity with the CoMFA and CoMSIA values containing magnitude of steric, electrostatic and hydrophobic potentials. The leave one out (LOO) cross-validation procedure by SAMPLS method was used to assess the models as implied in SYBYL (Bush and Nachbar, 1993). In addition to LOO cross-validation, a group cross-validation using 30 groups, repeating the procedure 30 times was also carried out. The mean of 30 readings is given as r 2cv(mean) . The full PLS analysis was carried out with a column filtering of 2.0 kcal/mol to speed up the calculation and reduce the noise.
Results and discussion
CoMFA and CoMSIA techniques were used to derive 3D-QSAR models on a set of 108 chemically diverse α1a-adrenoreceptor antagonists. The lowest energy conformation of all the compounds was considered for database alignment. Various 3D-QSAR models were generated and the best one was selected based on the statistically significant parameters obtained. The predictive power of the generated 3D-QSAR models was assessed by predicting biological activities of the test set molecules. The results of the CoMFA, CoMSIA studies have been summarized in Table 7.
CoMFA analysis
In CoMFA and CoMSIA studies though a q 2 value of 0.3 is considered statistically significant (Bohm et al., 1999) but a q 2 > 0.5 can be considered statistically more significant. The Tripos standard (TS) field showed the highest q 2 of 0.709 using five principal components with a high conventional r 2 value of 0.962 and low standard error of estimate (0.247) indicating it to be a statistically highly significant model. To further assess the robustness of this model, bootstrapping analysis (30 runs) was performed to give r 2bs of 0.979 (SDbs = 0.009) thus establishing the strength of the model. In addition to LOO, a group cross-validation was further done to assess the internal predictive ability of the model. The cross-validation for 30 times was performed with 30 groups and the mean r 2CV of 0.714 (TS) revealed that the model has good internal predictability and the results has no chance correlation (Table 3). A test set of 63 molecules was used to evaluate the predictivity of the generated model and a predictive r 2 of 0.629 showed good predictive ability of the generated model (Fig. 4a). The predictive pK i value of the training as well as test set molecules based on the CoMFA model has been included in Tables 1–6.
CoMSIA analysis
Various CoMSIA models were generated considering all possible combinations of field descriptors. In this study, steric (S), electrostatic (E) and hydrophobic (H) field descriptors were found to have an important role in the modulation of biological activity. The model having steric, electrostatic and hydrophobic fields gave the highest q 2 of 0.648 at five components and a conventional non-cross-validated r 2 of 0.949 among all the generated CoMSIA models (Table 4). To further assess the statistical ability and robustness of the model, bootstrapping analysis (30 runs) was performed where r 2bs of 0.966 with low standard deviation of 0.012 were obtained thus showing the robustness of the model. Similar to CoMFA, internal predictive ability of the model was accessed by group cross-validation performed with 30 groups. The mean r 2cv value of 0.649 revealed that the model has high internal predictivity. Further predictive r 2 of 0.656 for the 63 test set compounds showed the usefulness of the model (Fig. 4b). The Predictive pK i values of the training as well as test set molecules based on the CoMSIA model are included in Tables 1–6.
CoMFA and CoMSIA contour maps
The CoMFA and CoMSIA contour map analyses provided good insight into the SAR by providing a visual display of favored and disfavored positions. The steric and electrostatic features of the final CoMFA and the steric, electrostatic and hydrophobic features of CoMSIA models are displayed as contour maps of the PLS regression coefficients at each CoMFA/CoMSIA region grid point (Fig. 5). They are generated using the field type SD × coefficient to show the contribution for favorable and unfavorable interactions with the receptor in terms of steric (80% green, 20% yellow), electrostatic (80% blue and 20% red), hydrophobic (80% yellow, 20% white), donor (80% cyan, 20% purple) and acceptor (80% magenta, 20% red).
The surfaces near the template molecule 31 indicated the regions where the increase (green region) or decrease (yellow region) in steric bulk as well as increase (blue region) or decrease (red region) in electrostatic field would be important for the improvement of binding affinity. The yellow polyhydra in the hydrophobic contours show the region where an increase in hydrophobicity is favorable for α1a-adrenoreceptor antagonistic activity while white polyhydra denote the region where hydrophobicity is unfavorable for activity. The advantage of CoMSIA contour maps over CoMFA is that they are easier to interpret.
The CoMFA contours mainly showed four types of regions (Fig. 5a). The first and largest region is shown by green polyhedra (near the phenylchroman group) signified the importance of bulky steric group at this region which may be important for hydrophobic interactions with the receptor. The second one is blue polyhedra near the chroman moiety and phenoxy oxygen atom of the molecule 31 showed that there could be possibility of H-bond interactions at the binding site involving the oxygen atom of this molecule. The third yellow and fourth red polyhedral regions described the undesired steric group. Fourth red polyhedral region showed that the addition of negatively charged group at this region may increase in adrenergic antagonistic activity. The steric and electrostatic CoMSIA contours are also in well agreement with the CoMFA contours as shown in Fig. 5b. The contour plot of hydrophobic field as shown by white polyhydra (Fig. 5c) also suggested the importance of hydrophobic interaction near the phenylchroman group of the most active molecule 31 of the dataset.
Conclusion
The CoMFA and CoMSIA method has been applied successfully to rationalize the structurally diverse α1a-ARs antagonists covering a wide range of biological activity and structural features in terms of their steric, electrostatic and hydrophobic properties. The developed models showed good statistical significance in internal (q 2, group cross-validation and bootstrapping) validation and performed very well in predicting the biological activity (pK i) of the compounds in the test set. In view of the above, it may be concluded that the developed CoMFA and CoMSIA model can further be applied for the identification and optimization of novel scaffolds with potent α1a-adrenergic receptor antagonistic activity.
References
Barbaro R, Betti L, Botta M, Corelli F, Giannaccini G, Maccari L, Manetti F, Strappaghetti G, Corsano S (2001) Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward α1- and α2-adrenoceptors. J Med Chem 44:2118–2132
Bohm M, Sturzebecher J, Klebe G (1999) Three-dimensional quantitative structure-activity relationship analysis using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. J Med Chem 42:458–477
Brasili L, Sorbi C, Franchini S, Manicardi M, Angeli P, Marucci G, Leonardi A, Poggesi E (2003) 1,3-Dioxolane-based ligands as a novel class of 1-adrenoceptor antagonists. J Med Chem 46:1504–1511
Bush BL, Nachbar RB (1993) Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J Comput Aided Mol Des 7:587–619
Cramer RD III, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA): effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967
Debnath B, Samanta S, Naskar SK, Roy K, Jha T (2003) QSAR study on the affinity of some arylpiperazines towards the 5-HT1A/α1-adrenergic receptor using the E-state index. Bioorg Med Chem Lett 13:2837–2842
Fang H, Lu J-F, Xia L (2003) Constructing biophore of uroselective α1-adrenoceptor antagonist. J Chin Pharm Sci 12:188–191
Franchini S, Tait A, Prandi A, Sorbi C, Gallesi R, Buccioni M, Marucci G, DeStefani C, Cilia A, Brasili L (2009) (2, 2-Diphenyl-[1, 3]oxathiolan-5-ylmethyl)-(3-phenylpropyl)-amine: a potent and selective 5-HT1A receptor agonist. ChemMedChem 4:196–203
Fumagalli L, Bolchi C, Colleoni S, Gobbi M, Moroni B, Pallavicini M, Pedretti A, Villa L, Vistoli G, Valoti E (2005) QSAR study for a novel series of ortho monosubstituted phenoxy analogues of α1-adrenoceptor antagonist WB4101. Bioorg Med Chem 13:2547–2559
Jain KS, Bariwal JB, Kathiravan MK, Phoujdar MS, Sahne RS, Chauhan BS, Shah AK, Yadav MR (2008) Recent advances in selective α1-adrenoreceptor antagonists as antihypertensive Agents. Bioorg Med Chem 16:4759–4800
Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130–4146
Kulig K, Sapa J, Nowaczyk A, Filipek B, Malawska B (2009) Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3, 3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and a-adrenolytic activity. Eur J Med Chem 44:3994–4003
Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F (2004) Synthesis, screening, and molecular modeling of new potent and selective antagonists at the α1d -adrenergic receptor. J Med Chem 47:1900–1918
Li MY, Xia L (2007) Rational design, synthesis, biological evaluation, and structure–activity relationship studies of novel 1-Indanone α1-adrenoceptor antagonists. Chem Biol Drug Des 70:461–464
Li MY, Tsai K-C, Xia L (2005) Pharmacophore identification of α1a-adrenoceptor antagonists. Bioorg Med Chem Lett 15:657–664
MacDougall IJA, Griffith R (2006) Selective pharmacophore design for α1-adrenoceptor subtypes. J Mol Graph Model 25:146–157
Maciejewska D, Zołek T, Herold F (2006) CoMFA methodology in structure-activity analysis of hexahydro and octahydropyrido[1, 2-c]pyrimidine derivatives based on affinity towards 5-HT1A, 5-HT2A and α1-adrenergic receptors. J Mol Graph Model 25:353–362
Nowaczyk A, Kulig K, Malawska B (2009) 1-(3-(4-Arylpiperazin-1-yl)-propyl)-pyrrolidin-2-one derivatives as α1-adrenoceptor antagonists: a QSAR study. QSAR Comb Sci 28:979–988
Pallavicini M, Fumagalli L, Gobbi M, Bolchi C, Colleoni S, Moroni B, Pedretti A, Rusconi C, Vistoli G, Valoti E (2006) QSAR study for a novel series of ortho disubstituted phenoxy analogues of α1-adrenoceptor antagonist WB4101. Eur J Med Chem 41:1025–1040
Prathipati P, Saxena AK (2003) Comparison of MLR. PLS and GA-MLR in QSAR analysis. SAR QSAR Environ Res 14:433–446
Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C (1999) Structure–activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for 1-adrenoreceptor subtypes. J Med Chem 42:2961–2968
Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C (2002) Structure−activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for α1-adrenoreceptor subtypes. J Med Chem 45:1633–1643
Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarin PI, Poggesi E, Leonardi A, Giannella M (2005) Structure–activity relationships in 1,4-benzodioxan-related compounds.8.1{2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine clopenphendioxan) as a tool to highlight the involvement of 1d- and 1β-adrenoreceptor subtypes in the regulation of human pc-3 prostate cancer cell apoptosis and proliferation. J Med Chem 48:7750–7763
Quaglia W, Piergentili A, Bello FD, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A (2008) Structure activity relationships in 1,4-benzodioxan-related compounds. 9. (1) From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel α1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. J Med Chem 51:6359–6370
Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP (2003) New pyrimido[5,4-b]indoles as ligands for α1-adrenoceptor subtypes. J Med Chem 46:2877–2894
Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C (2003) Prazosin-related compounds: effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for α1-adrenoreceptors. J Med Chem 46:4895–4903
Roy KK, Dixit A, Saxena AK (2008) An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis. J Mol Graph Model 27:197–208
Shakya N, Fatima Z, Saxena AK (2004) 3D-QSAR studies on substituted dihydropyridines for their α1a-adrenergic receptor binding affinity. Med Chem Res 13:812–823
Sorbi C, Franchini S, Tait A, Prandi A, Gallesi R, Angeli P, Marucci G, Pirona L, Poggesi E, Brasili L (2009) 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure–affinity/activity relationships at a1 and 5-ht1a receptors. ChemMedChem 4:393–399
Tripos Inc. (1699) South Hanley Road, St. Louis, 63144
Acknowledgments
The technical assistance of Mr. A.S. Kushwaha is gratefully acknowledged during this work. One of the authors AKG acknowledges CSIR, New Delhi for financial support.
Author information
Authors and Affiliations
Corresponding author
Additional information
CDRI communication No. 7942.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gupta, A.K., Saxena, A.K. 3D-QSAR CoMFA and CoMSIA studies on a set of diverse α1a-adrenergic receptor antagonists. Med Chem Res 20, 1455–1464 (2011). https://doi.org/10.1007/s00044-010-9379-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-010-9379-1